A Phase III, Placebo-Controlled, Double-Blind, Randomized Trial Assessing the Effect of Tramiprosate on Hippocampus Volume Change in Patients with Mild-to-Moderate Alzheimer's Disease (The Alphase Study)

被引：0
|
作者：
Gauthier, Serge
Aisen, Paul
Ferris, Steven
Garceau, Denis
Saumier, Daniel
Duong, Anh
Sampalis, John
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A246 / A247
页数：2
相关论文
共 50 条
  • [41] Deer Bone Extract Supplementation for Mild-to-Moderate Knee Osteoarthritis Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial
    Shin, Dongseok
    Kim, Eun Ae
    Kim, Yoon Young
    Kim, Min Seo
    Kim, Jong Hoon
    Ahn, Chang Won
    Park, Soo-Hyun
    Lee, Ki Won
    Kim, Jae Hwa
    Kim, Ji Yeon
    JOURNAL OF MEDICINAL FOOD, 2018, 21 (02) : 159 - 166
  • [42] Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Bruno Dubois
    Jesús López‑Arrieta
    Stanley Lipschitz
    Triantafyllos Doskas
    Luiza Spiru
    Svitlana Moroz
    Olena Venger
    Patrick Vermersch
    Alain Moussy
    Colin D. Mansfield
    Olivier Hermine
    Magda Tsolaki
    Alzheimer's Research & Therapy, 15
  • [43] Dimebon improves cognition, function, and behavior in patients with mild- moderate Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled study
    Doody, Rochelle
    Gavrilova, Svetlana
    Sano, Mary
    Thomas, Ronald
    Aisen, Paul
    Seely, Lynn
    Hung, David
    NEUROLOGY, 2007, 68 (12) : A353 - A353
  • [44] The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial
    Alireza Yargholi
    Leila Shirbeigi
    Roja Rahimi
    Parvin Mansouri
    Mohammad Hossein Ayati
    BMC Research Notes, 14
  • [45] Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study
    Florian, Hana
    Meier, Andreas
    Gauthier, Serge
    Lipschitz, Stanley
    Lin, Yunzhi
    Tang, Qi
    Othman, Ahmed A.
    Robieson, Weining Z.
    Gault, Laura M.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1237 - 1247
  • [46] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [47] The effect of Melissa officinalis syrup on patients with mild to moderate psoriasis: a randomized, double-blind placebo-controlled clinical trial
    Yargholi, Alireza
    Shirbeigi, Leila
    Rahimi, Roja
    Mansouri, Parvin
    Ayati, Mohammad Hossein
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [48] A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SINGLE, NEBULIZED DOSES OF EXOSURF(TM) (EXO) IN PATIENTS WITH MILD-TO-MODERATE ASTHMA
    SORKNESS, C
    MCGILL, K
    BROWN, DL
    SORKNESS, R
    BUSSE, W
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 352 - 352
  • [49] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    M. Panisset
    S. Gauthier
    H. Moessler
    M. Windisch
    Journal of Neural Transmission, 2002, 109 : 1089 - 1104
  • [50] DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial - Reply
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Yaffe, K
    NEUROLOGY, 2004, 62 (06) : 1030 - 1030
12345